JAGX
Jaguar Health, Inc.
-0.80 (-22.94%)2.69USD140K成交股數461M市值0.0本益比(近四季)16.6股價營收比-58.9%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.2M-59% | 20.3M+816% | 3.2M+4% | 3.1M+13% | 3.0M+27% | 2.2M | 3.1M+10% | 2.7M | 2.4M | – | 2.8M | – |
| 營業成本 | 1.0M | 1.2M | −1.0M | 532K | 97K | 515K | 541K | 427K | 430K | 687K | 514K | 491K |
| 毛利 | 194K-93% | 19.1M+1025% | 4.3M+67% | 2.6M+11% | 2.9M+50% | 1.7M | 2.6M+12% | 2.3M | 1.9M | – | 2.3M | – |
| 毛利率 | 15.8% | 94.3% | 132.4% | 82.7% | 96.7% | 76.7% | 82.6% | 84.3% | 81.7% | – | 81.7% | – |
| 研發費用 | 3.3M | 3.9M | 14.3M | 3.7M | 3.3M | 3.7M | 4.0M | 3.7M | 4.3M | 3.5M | 6.1M | 4.3M |
| 銷售管理費用 | 4.5M | 4.1M | 4.9M | 4.1M | 4.7M | 4.9M | 3.8M | 4.3M | 4.4M | 3.8M | 3.5M | 4.4M |
| 營業利益 | −7.6M-5% | 10.2M-208% | −21.2M+193% | −7.2M+1% | −8.0M-3% | −9.4M+25% | −7.3M-17% | −7.2M-11% | −8.2M | −7.6M | −8.8M | −8.1M |
| 營業利益率 | -620.2% | 50.2% | -656.6% | -234.8% | -268.8% | -425.5% | -233.7% | -264.5% | -349.4% | – | -312.4% | – |
| 稅後淨利 | −12.8M+23% | 8.7M-183% | 30.3M-408% | −9.5M+0% | −10.4M+13% | −10.5M-133% | −9.9M+27% | −9.5M-22% | −9.2M | 32.1M | −7.8M | −12.2M |
| 淨利率 | -1,045.1% | 43.0% | 937.2% | -308.2% | -349.3% | -472.6% | -317.1% | -348.8% | -392.4% | – | -276.5% | – |
| 稀釋 EPS | -15.70-96% | -13.60-98% | 926.70-3625% | -6.28+136% | -358.94+312% | -584.45-78% | -26.29+17% | -2.66-94% | -87.12 | -2611.93 | -22.50 | -41.35 |
| 稀釋股數 | 809K | 516K | 2.3M | 1.5M | 29.0K | 17.9K | 375K | 3.6M | 106K | 15.4K | 346K | 294K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 3.8M | 7.3M | 968K | 3.5M | 2.2M | 5.7M | 13.3M | 16.0M | 11.7M | 6.5M | 3.2M | 8.6M |
| 應收帳款 | 8K | 68K | 1.5M | 1.4M | 1.2M | 1.2M | 1.2M | 1.3M | 1.5M | 2.0M | 1.7M | 1.4M |
| 存貨 | 7.3M | 7.8M | 8.6M | 10.6M | 10.7M | 10.6M | 9.7M | 9.6M | 9.0M | 9.2M | 8.4M | 8.3M |
| 總資產 | 34.2M | 37.4M | 38.3M | 49.5M | 48.3M | 51.5M | 58.5M | 61.5M | 55.4M | 50.8M | 45.4M | 52.2M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 29.3M | 53.2M | 57.0M | 45.1M | 41.4M | 48.1M | 42.9M | 42.4M | 41.1M | 45.9M | 44.0M | 46.3M |
| 股東權益 | 4.9M | −15.8M | −18.7M | 4.4M | 6.9M | 830K | 13.1M | 16.6M | 11.8M | 4.9M | 1.4M | 5.8M |
| 負債比 | 85.6% | 142.1% | 148.8% | 91.2% | 85.7% | 93.6% | 73.3% | 69.0% | 74.2% | 90.4% | 96.9% | 88.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 8.8M-221% | – | – | – | −7.3M | – | – | −7.0M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 473K | – | – | – | 479K | – | – | 501K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 11.5M
| Human Health | 11.2M | 96.9% | -1.9% |
|---|---|---|---|
| Animal Health | 353K | 3.1% | +12.1% |
產品／服務2025 年度 · 11.5M
| 產品 | 11.3M | 98.5% | -1.9% |
|---|---|---|---|
| License | 172K | 1.5% | +33.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 11.5M | -1.5% | −54K | -0.5% | -22.97 | – |
| FY2024 | 11.7M | +19.8% | −39K | -0.3% | -130.69 | −29.4M |
| FY2023 | 9.8M | -18.4% | −42K | -0.4% | -2678.17 | – |
| FY2022 | 12.0M | +175.8% | −48K | -0.4% | -36.18 | −33.2M |
| FY2021 | 4.3M | -53.8% | −53K | -1.2% | -88.22 | −35.0M |
| FY2020 | 9.4M | +62.5% | −33.8M | -360.2% | -3.00 | −15.3M |
| FY2019 | 5.8M | +30.8% | −38.5M | -667.3% | -9.01 | – |
| FY2018 | 4.4M | – | −32.1M | -727.9% | -153.27 | −22.7M |